Prognostic usefulness of serum lactic dehydrogenase and its fifth isoenzyme levels in carcinoma of the prostate
Author:
- 1 September 1976
- journal article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 8 (3) , 221-225
Abstract
Antiandrogenic treatment with castration, intravenous diethylstilbestrol diphosphate and oral estradiol benzoate was given to 51 patients with prostatic carcinoma. The interrelationship between the clinical response to this treatment and the changes of serum lactic dehydrogenase (SLDH) and SLDH isoenzyme V fraction (SLDH-V) level was studied. Pretreatment SLDH level is significant in regard to the 5-year survival rate. Response of SLDH and SLDH-V levels to antiandrogenic treatment has no significant influence on the 5-year survival rates. As regards the index of the 5-year survival rate in patients with prostatic carcinoma, SLDH-V was almost as specific as SLDH.Keywords
This publication has 5 references indexed in Scilit:
- Serum Lactic Dehydrogenase Isoenzyme V Fraction in Prostatic CarcinomaUrologia Journal, 1976
- Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinomaCancer, 1969
- ALTERATIONS IN SERUM LACTIC DEHYDROGENASE AND ITS ISOZYMES IN PATIENTS WITH PROSTATIC CARCINOMA AFTER HORMONAL THERAPY.1964
- LACTIC DEHYDROGENASE IN PROSTATIC CANCER.1963
- Über das Verhalten und die Herkunft glykolytischer Serumenzyme beim Menschen und ihre diagnostische BedeutungJournal of Molecular Medicine, 1958